A study evaluating the Safety and Efficacy of Entospletinib (GS-9973) in combination with standard of care in adult subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate safety of entospletinib (GS-9973) in combination with vincristine (VCR) and dexamethasone in adult subjects with previously treated relapsed or refractory B-cell lineage ALL

Critère d'inclusion

Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Liens

ictrp
euctr